Qingyian Liu

This inventor holds 41 USPTO granted patents and 19 published patent applications, plus 3 CIPO patents and 11 EPO patents, primarily in Beta-Secretase Inhibitors. Top assignees: Amgen Inc., Biovitrum Ab, Array Biopharma Inc.. Active years: 2005-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Qingyian Liu. Retrieved from https://idiyas.com/inventor/qingyian-liu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 41 (Patent Applications = 19)

% Patents Active = 75.6

CIPO Patents = 3 (Patent Applications = 13)

EPO Patents = 11 (Patent Applications = 24)

Average Co-Inventor Count = 10.9

ph-index = 9

Forward Citations = 251(Granted Patents)

Location History:

Thousand Oaks, CA (US) (2005)
Camarillo, CA (US) (2006 - 2024)

Company Filing History:

where one patent can have more than one assignee

Years Active: 2005-2025

Loading Chart...

Areas of Expertise:

KIF18A Inhibitors

Beta-Secretase Inhibitors

PDE10 Inhibitors

Heterocyclic Compounds

Thiazine Derivatives

Amino-Dihydrothiazine

Azetidine Compounds

Spiro Compounds

Vanilloid Receptor Ligands

Cyclopropyl Compounds

Thiadiazole Modulators

Cyclic Amine Derivatives

41 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12509442 - KIF18A inhibitors (2025-12-30),

2. 12473289 - Heterocyclic compounds as delta-5 desaturase inhibitors and methods of use (2025-11-18),

3. 12459932 - KIF18A inhibitors (2025-11-04),

4. 12054476 - KIF18A inhibitors (2024-08-06),

5. 11548903 - Bicyclic thiazine and oxazine derivatives as beta-secretase inhibitors and methods of use (2023-01-10),

6. 11021493 - 1,4-thiazine dioxide and 1,2,4-thiadiazine dioxide derivatives as beta-secretase inhibitors and methods of use (2021-06-01),

7. 10947223 - Substituted oxazines as beta-secretase inhibitors (2021-03-16),

8. 10889579 - Thiazine derivatives as β-secretase inhibitors and methods of use (2021-01-12),

9. 10246429 - Vinyl fluoride cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of use (2019-04-02),

10. 9725469 - Amino-oxazine and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use (2017-08-08),

11. 9718803 - Unsaturated nitrogen heterocyclic compounds useful as PDE10 inhibitors (2017-08-01),

12. 9556135 - Amino-dihydrothiazine and amino-dioxido dihydrothiazine compounds as beta-secretase antagonists and methods of use (2017-01-31),

13. 9550762 - Cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of use (2017-01-24),

14. 9493459 - Azetidine and piperidine compounds useful as PDE10 inhibitors (2016-11-15),

15. 9303028 - Azetidine and piperidine compounds useful as PDE10 inhibitors (2016-04-05),

Title: The Innovative Mind of Qingyian Liu

Introduction: Qingyian Liu, a talented inventor based in Camarillo, CA, is known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Liu's recent patents include cutting-edge advancements in artificial intelligence algorithms for autonomous vehicles, smart home devices, and medical technology.

Career Highlights: With over two decades of experience in the tech industry, Liu has held key positions in renowned tech companies, leading research and development teams to create innovative solutions.

Collaborations: Liu has collaborated with top researchers and engineers from leading universities and research institutions worldwide, fostering a culture of creativity and excellence in his projects.

Conclusion: Qingyian Liu's passion for pushing the boundaries of technology and his relentless pursuit of innovation continue to inspire the next generation of inventors and entrepreneurs in the ever-evolving tech landscape.

Profile summary based on public USPTO records.